Monday, November 25, 2013

Lexiscan (regadenoson) and Adenoscan (adenosine): Drug Safety Communication - Rare but Serious Risk of Heart Attack and Death

1. Screen all nuclear stress test candidates for their suitability to receive Lexiscan or Adenoscan. 
2. Avoid using these drugs in patients with signs or symptoms of unstable angina or cardiovascular instability, as these patients may be at greater risk for serious cardiovascular adverse reactions. 
3. Cardiac resuscitation equipment and trained staff should be available before administering Lexiscan or Adenoscan.http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm375981.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

No comments:

Post a Comment